Sensus Healthcare Inc is primarily active in the healthcare industry.

The main competitors of Sensus Healthcare Inc in the market include Varian Medical Systems Inc, Cutera Inc, and Elekta AB.

Sensus Healthcare Inc. is a renowned medical device company specializing in non-invasive treatments for various skin cancers and other dermatological conditions. Founded in 2010, Sensus Healthcare has grown into a global leader in superficial radiation therapy (SRT) technology. Their flagship product, the SRT-100™, provides effective, painless, and non-surgical treatment options to patients around the world. With a strong focus on innovation and patient-centric approach, Sensus Healthcare continues to revolutionize the field of dermatology. As a result, it is recognized for its cutting-edge technology, exceptional clinical outcomes, and dedication to improving the quality of life for patients with skin disorders.

Sensus Healthcare Inc has achieved several significant milestones. Firstly, the company received FDA clearance for its Scalp and Superficial Radiation Therapy System in 2005, allowing it to provide non-invasive treatments for various skin conditions. Additionally, Sensus Healthcare was listed on the NASDAQ stock exchange in 2016, further solidifying its presence in the market. In recent years, the company has expanded its global reach, establishing partnerships and increasing its customer base worldwide. Sensus Healthcare Inc also continues to innovate, developing advanced technologies and treatment solutions to improve patient outcomes. These milestones showcase the company's dedication to advancing dermatological care and its commitment to growth and innovation.

Sensus Healthcare Inc is primarily present in the United States, with their headquarters located in Boca Raton, Florida. As a global medical device company, they have a widespread presence across various states and cities within the US. Additionally, Sensus Healthcare Inc has expanded its reach to numerous other countries and regions worldwide, including Europe, Asia, and Latin America. With a commitment to providing innovative solutions for non-invasive skin cancer treatment, Sensus Healthcare Inc continues to extend its presence and impact in the international market.

Sensus Healthcare Inc represents a set of core values and a corporate philosophy that drives its operations. The company aims to deliver innovative and effective solutions for non-invasive skin cancer treatment. With a focus on patient care and quality, Sensus Healthcare strives to provide advanced technology and therapies to improve treatment outcomes. By offering personalized solutions and maintaining strong ethical standards, Sensus Healthcare ensures that patients receive the best possible care. The company's commitment to research, development, and collaboration with healthcare professionals reflects its dedication to advancing the field of dermatology and oncology. Sensus Healthcare Inc sets high standards in delivering exceptional services to patients worldwide.

Analysts currently set an average price target of 6,80 USD for the Sensus Healthcare stock (median: 6,12 USD), implying +114,0 % versus the latest price. The consensus is based on 9 analyst ratings.

Sensus Healthcare Analyytikkojen kursstavoitteet 2026

9 analysts currently rate the Sensus Healthcare stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Sensus Healthcare to generate revenue of 21,99 M USD and earnings per share of −0,42 USD.

Sensus Healthcare Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the Sensus Healthcare share trades at 2,68 EUR (3,09 USD).

The Sensus Healthcare share (SRTS) is listed on 4 stock exchanges, including: NASDAQ (SRTS), Frankfurt (5TX.F), München (5TX.MU), Düsseldorf (5TX.DU).

Sensus Healthcare Inc. is an innovative company specializing in the development and marketing of medical devices and solutions for dermatology and oncology. The company offers a wide range of products and services aimed at the treatment of skin cancer, psoriasis, and other dermatological conditions. The business model of Sensus Healthcare focuses on the following areas: 1. Distribution of medical devices and solutions: Sensus Healthcare distributes a range of medical devices and solutions used in modern medicine for the treatment of skin cancer, psoriasis, and other dermatological conditions. These include the Superficial Radiation Therapy (SRT) system, electronic brachytherapy system, and phototherapy solutions. 2. Consumables and accessories: The company also offers various consumables and accessories for the medical devices it provides. These consumables include X-ray films, protective films, and electrodes. 3. Services and support: In addition to selling medical devices and accessories, Sensus Healthcare also offers various services and support to its customers. These include training and technical support, installation services, as well as maintenance and repair services. Sensus Healthcare has also focused on continuously improving the quality and effectiveness of its products. The company has established an extensive research and development program that allows it to constantly improve its products and introduce new innovative solutions to the market. Another important aspect of Sensus Healthcare's business model is its direct collaboration with doctors and medical facilities worldwide. The company has built a global network of distribution partners and collaborators to provide better coverage and support to its customers. In terms of its products, Sensus Healthcare offers a variety of solutions including: 1. The Superficial Radiation Therapy (SRT) system is a non-invasive, painless treatment method specifically designed for skin cancer, basal cell carcinoma, and other dermatological conditions. The SRT system delivers targeted radiation therapy that only treats the affected areas of the skin without damaging the surrounding tissue or organs. 2. The electronic brachytherapy system is another therapy option offered by Sensus Healthcare. This system can deliver targeted radioactive radiation directly into the tumor to destroy cancer cells. The electronic brachytherapy system is particularly effective in the treatment of skin cancer, melanoma, and other malignant skin conditions. 3. Phototherapy solutions are also an important part of Sensus Healthcare's offerings. Phototherapy is a non-invasive treatment that uses targeted ultraviolet light to treat psoriasis, eczema, and other skin conditions. Overall, Sensus Healthcare's business model is characterized by a targeted focus on providing innovative medical devices and solutions. Through its wide range of products, extensive support network, and emphasis on collaboration with medical facilities worldwide, the company has achieved a strong position in the industry.

odotettu liikevaihto Sensus Healthcare on 21,99 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Sensus Healthcare on −6,82 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Sensus Healthcare:n hinta-voitto-suhde (P/E) on tällä hetkellä −7,40. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Sensus Healthcare-osakkeen arvostusta.

Sensus Healthcare:n hinta-myynti-suhde (P/S) on tällä hetkellä 2,29. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Sensus Healthcare-osakkeen arvostuskennuslukuna.

Sensus Healthcare:n Eulpool-laatuscore on 1/10.

Sensus Healthcare:n ISIN on US81728J1097. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Sensus Healthcare:n WKN on A2JPJ1. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Sensus Healthcare:n ticker on SRTS. Tämä pörssinoteeraus käytetään Sensus Healthcare-osakkeiden kauppaan pörssissä.

Sensus Healthcare maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

Sensus Healthcare kuuluu sektoriin 'Terveydenhuolto'.

Sensus Healthcare:n osingot jaetaan valuutassa USD.